Skip to main content

Table 1 Demographic and clinical characteristics of study subjects

From: IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis

  HIV-LTBI- HIV-LTBI+ HIV + LTBI- HIV + LTBI+ HIV + TB+
Number of participants 35 40 35 40 40
Mean age 34.4 ± 6.9 31.7 ± 7.1 32.4 ± 8.3 33.1 ± 6.5 34.6 ± 6.2
Percentages of males and females 51, 49 55,45 43, 57 56,44 61,39
BCG scar percentage 90% 85% 70% 68% 73%
History of TB infection No No No No No
Mean CD4 counts 747 ± 356 869 ± 408.9 408 ± 307.1 525 ± 323.3 250 ± 259
Mean CD8 counts 836 ± 420.3 728 ± 334.3 1187 ± 606.7 1227 ± 913.5 663 ± 501.6
Mean years of onset of HIV infection NA NA 9 10 NA
ART treatment NA NA No No No
  1. NA = Not Applicable, HIV-LTBI-: HIV negative healthy individuals without latent TB infection, HIV-LTBI+: HIV negative healthy individuals with latent TB infection. HIV + LTBI-: HIV patients without latent TB, HIV + LTBI+: HIV patients with latent TB, HIV + TB+: HIV patients with active tuberculosis